Hemodialysis Vascular Grafts Market to Set Phenomenal Growth from 2018 to 2026

The hemodialysis vascular grafts market is set to reach from US$ 196.6 Mn in 2017 to US$ 285.2 Mn by 2026 representing balanced growth at a compounded annual growth rate (CAGR) of 4.3% during the forecast period from 2018 to 2026. Atrial fibrillation is the most common type of cardiac arrhythmia diagnosed globally. According to the research findings brought forward by World Health Organization (WHO), the number of end stage renal disease patients worldwide receiving dialysis will be approximately 5.24 million by 2030. The common causes associated with morbidity during hemodialysis are infection, hemorrhage and vascular grafts rejection. Synthetic materials are being made with a blend of polymers to achieve the desired materials strength, adhesion, durability and pliability. Bioengineered materials will be the latest trendsetter due to advantages associated with it such as negligible graft rejection and excellent biocompatibility.

Browse the full report Hemodialysis Vascular Grafts Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/hemodialysis-vascular-grafts-market

Market Insights

End stage renal disease (ESRD) is a medical condition in which the kidney functions only 10% of its natural ability to perform excretion of toxic material from the human blood. When the glomerular filtration rate of the kidney is <15 ml/min/1.73 m2, patient is reported with end stage renal failure. Diabetes and hypertension are the chief causative factors in chronic kidney disease. Chronic kidney disease has a global prevalence rate between 11 to 13% in stage 3 ESRD. The role of vascular grafts in hemodialysis procedure is to attain blood flow from one area to the other by connecting blood vessels.

Polyurethane is mixed in different concentration to achieve vascular graft with improved tensile strength and larger inner luminal diameter to promote smooth blood transfusion during hemodialysis procedure. Polytetrafluoroethylene currently dominates the raw material segment for hemodialysis vascular grafts market. Its inherent features such as high adhesion, excellent native fistula pliability and reimburesemnt scenario drive the market growth. Bioengineered materials will be the latest trendsetter during the forecast period due to improved material characteristics which prevent infection, hemorrhage and graft rejection occurring during hemodialysis procedure in patients suffering with chronic kidney disease.

With a market share of 36% North America is the largest regional market in hemodialysis vascular grafts market. The properties influencing its dominant growth are increasing geriatric population suffering with end stage renal disease and higher healthcare expenditure. Existence of market leaders such as C.R.Bard, Inc., Terumo Medical Corporation and CryoLife, Inc. etc. further propel the hemodialysis vascular grafts market in the North America region. Europe currently holds 28% share owing to features such as supportive reimbursement scenario associated with hemodialysis vascular grafts and increasing demand for hemodialysis procedures compared to intraperitoneal dialysis in patients suffering with chronic kidney disease. Asia Pacific represents 20% share and is set to engrave positive growth in the near future due to proactive government policies to fight renal disease and rapid growth in medical tourism.

Pharmaceutical companies manufacturing hemodialysis vascular grafts are C.R.Bard, Inc., CryoLife, Inc., Getinge AB., InnAVasc Medical, Inc., LeMaitre Vascular, Inc., Merit Medical Systems, Inc., Proteon Therapeutics, Inc., Terumo Medical Corporation, Vascular Genesis and W.L.Gore Associates.

Key Market Movements:

  • Increasing morbidity associated with hemodialysis procedures in patients suffering with end stage renal diseases
  • Different blends of synthetic polymers are mixed e.g. polyurethane and polytetrafluoroethylene to achieve the desired native fistula pliability and adhesion properties
  • Technical innovations in bioengineered raw materials to drastically reduce infection, graft rejection and hemorrhage occurring in hemodialysis procedures

For More In-depth Information Get Sample PDF: https://www.credenceresearch.com/sample-request/59569

Comments

comments

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *